In response to the 2014 outbreak, International Medical Corps ran five Ebola treatment units in Sierra Leone and Liberia

ViroStat has introduced new sets of monoclonal antibodies to two of the significant antigens of this virus; Nucleoprotein (NP) and VP40

The findings, published online May 18 in the journal Cell, could lead to the first broadly effective ebolavirus therapies and vaccines

Educating people in areas affected by Ebola about how the disease spreads through communities is consistently the most effective strategy for halting an epidemic

The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year

Advance could also work against other viruses

Important lessons learned from the response to Ebola could improve our response to Zika, report says

U-M researchers studied the U.S. response to Ebola and found a fragmented system with no clear leadership, and considerable "strategic politicization" 

Inexpensive method could slow spread of outbreak, future pandemic diseases

A research team that included scientists from The Scripps Research Institute (TSRI) has identified a new group of powerful antibodies to fight Ebola virus.